Riverwater Partners’s iRadimed IRMD Stock Holding History

Riverwater Partners’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,285	Closed	-$220K	–	222
2026 Q1	$220K	Sell	2,285 -779	-25%	-$77.9K	0.07%	206
2025 Q4	$298K	Hold	3,064	–	–	0.12%	174
2025 Q3	$218K	Buy	+3,064	New	+$204K	0.09%	206
2025 Q1	–	Sell	-7,570	Closed	-$416K	–	218
2024 Q4	$416K	Sell	7,570 -2,549	-25%	-$134K	0.2%	119
2024 Q3	$502K	Sell	10,119 -506	-5%	-$23.3K	0.25%	109
2024 Q2	$467K	Sell	10,625 -1,129	-10%	-$48K	0.35%	83
2024 Q1	$517K	Sell	11,754 -177	-1%	-$7.82K	0.38%	75
2023 Q4	$566K	Buy	11,931 +295	+3%	+$12.4K	0.45%	62
2023 Q3	$516K	Buy	11,636 +5,402	+87%	+$251K	0.47%	62
2023 Q2	$298K	Hold	6,234	–	–	0.26%	129
2023 Q1	$245K	Buy	+6,234	New	+$227K	0.23%	147

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Riverwater Partners's IRMD Position: Q2 2026 in Review

Riverwater Partners sold out of iRadimed (IRMD) in Q2 2026, closing a stake of 2,285 shares — an estimated $220K sold.

Riverwater Partners first reported a position in IRMD in Q1 2023 and held it in 11 quarters. The position peaked at $566K in Q4 2023. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Riverwater Partners reported no remaining iRadimed position as of Q2 2026 after selling out during the quarter.
Riverwater Partners sold 2,285 iRadimed shares in Q2 2026, an estimated $220K.
Riverwater Partners first reported a position in iRadimed in Q1 2023 and held it in 11 quarters.
Riverwater Partners's iRadimed position peaked at $566K in Q4 2023.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Riverwater Partners's 13F filing for Q2 2026, filed 14 Aug 2026.